Wanna buy a medical device startup? A down payment would be nice. As competition for medical device acquisitions heats up, Medtronic Inc. (NYSE:MDT) and Boston Scientific Corp. (NYSE:BSX) are redeeming early bets on promising startups.
Ardian Inc. is a startup based in Mountain View, California. Yet its technology, a catheter-based treatment for hypertension, was created by Minnesota entrepreneurs, funded by a Minnesota venture capital firm, tested by a Minnesota hospital, and recently bought by a Minnesota medical device company for at least $800 million. Are you as disturbed about this as I am?
In mid-May, Cameron Health Inc. struck media gold when the New York Times and the New England Journal of Medicine both gave prominent coverage to the company's efforts to develop the medical device industry's first subcutaneous implantable cardioverter defibrillator (ICD). Not bad for a relatively unknown startup in San Clemente, California. But a week earlier, Cameron struck managerial gold when it hired Warren Watson.
Medtronic Inc. (NYSE:MDT) is quietly working on plans to develop a pacemaker that can deliver electricity to the heart without wires. The company, based in Fridley, Minnesota, confirmed to MedCity News begin_of_the_skype_highlighting end_of_the_skype_highlighting that it's building a leadless pacemaker but offered no further details on the device, which reportedly can be implanted directly into the right ventricle.
The Heart Rhythm Society annual meeting is arguably the most important conference for big cardiac medical device makers like Medtronic Inc. (NYSE: MDT), based in Fridley, Minn., and Boston Scientific Corp. (NYSE: BSX). It’s an ideal forum for companies to release significant clinical data: Medtronic, for example, Thursday demonstrated methods to reduce accidental shocks from […]
